window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Development

  • Biomanufacturing,Drug Development,Medical devices,Pharmaceuticals and therapeutics,Technology and platforms

    Thermo Fisher launches DXR3 SmartRaman+ for at-line pharmaceutical and industrial testing

    Thermo Fisher Scientific has launched the DXR3 SmartRaman+ Raman Spectrometer [...]

    January 14, 2026
  • Artificial Intelligence,Biotech,Drug Development,Mergers & Acquisitions,Technology and platforms

    CombinAbleAI to be acquired by insitro to expand AI drug discovery platform

    AI therapeutics company, insitro, has agreed to acquire CombinAbleAI in [...]

    January 14, 2026
  • Artificial Intelligence,Biotech,Drug Development,Pharmaceuticals and therapeutics,Precision medicine,Research & Development,Technology and platforms

    CytoReason unveils LINA, AI agent accelerated by NVIDIA for pharma R&D

    CytoReason has unveiled LINA, an AI agent designed to support [...]

    January 13, 2026
  • Biologics & Biosimilars,Biotech,Clinical Development,Clinical Trials,Drug Development,Oncology,Pharmaceuticals and therapeutics,Research & Development

    Bicara announces Phase 3 optimal dose for ficerafusp alfa and provides 2026 corporate outlook

    Bicara Therapeutics has selected 1500 mg of ficerafusp alfa as [...]

    January 13, 2026
  • Biologics & Biosimilars,Biotech,Drug Development,Precision medicine,Research & Development,Technology and platforms

    Nuclera extends Series C funding to $87M to advance antibody engineering

    Nuclera has extended its Series C funding to a total [...]

    January 13, 2026
  • Biologics & Biosimilars,Biotech,Drug Development,Oncology,Pharmaceuticals and therapeutics,Technology and platforms

    Bio‑Sourcing and Zerion Pharma collaborate on first oral HER2 monoclonal antibody

    Bio‑Sourcing and Zerion Pharma have joined forces to develop the [...]

    January 12, 2026
  • CDMOs & Manufacturing,Drug Development,Events and Conferences,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    CPhI & PMEC India 2025 showcases pharma innovation and sets stage for expanded 2026 edition

    The 18th edition of CPhI & PMEC India, South Asia’s [...]

    January 12, 2026
  • Biologics & Biosimilars,Biotech,Drug Development,Pharmaceuticals and therapeutics,Technology and platforms

    FairJourney Bio launches cryo-EM services from San Diego laboratories

    FairJourney Bio (FJBio) has expanded its portfolio with the launch [...]

    January 12, 2026
  • Biologics & Biosimilars,Biotech,Drug Development,Pharmaceuticals and therapeutics,Technology and platforms

    Argobio-backed Enodia raises €20.7 million seed to advance small-molecule protein degradation platform

    Argobio Studio has announced the successful seed financing of Enodia [...]

    January 12, 2026
  • Clinical Development,Drug Development,Oncology,Pharmaceuticals and therapeutics

    Shilpa Medicare targets US approval for extended-release ondansetron injection

    Shilpa Medicare Limited is targeting US approval for its Ondansetron [...]

    January 12, 2026
Previous567Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Click Therapeutics secures $50M from Boehringer Ingelheim for schizophrenia digital therapy
    Categories: Clinical Development, Clinical Trials, Digital Health, Funding, Mental health, Neurosciences, Pharmaceuticals and therapeutics
  • Kainova Therapeutics doses first patient in Europe in phase 1/2 anti-CCR8 antibody trial
    Categories: Clinical Trials, Oncology
  • START appoints Salwan Al Mutar to lead clinical research in Dallas-Fort Worth
    Categories: Clinical Development, Clinical Trials, Healthcare leadership, Oncology
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top